(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1317502 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of SH2D4A mRNA CTD PMID:22079256 1,3-dinitrobenzene increases expression ISO RGD:1307991 6480464 3-dinitrobenzene results in increased expression of SH2D4A mRNA CTD PMID:21983209 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SH2D4A mRNA CTD PMID:19933214 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317502 6480464 Tetrachlorodibenzodioxin results in decreased expression of SH2D4A mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1307991 6480464 Tetrachlorodibenzodioxin results in decreased expression of SH2D4A mRNA CTD PMID:21215274 2,5-hexanedione decreases expression ISO RGD:1307991 6480464 2, 5-hexanedione results in decreased expression of SH2D4A mRNA CTD PMID:22952946 2-hydroxypropanoic acid decreases expression ISO RGD:1317502 6480464 Lactic Acid results in decreased expression of SH2D4A mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1317502 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SH2D4A mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO RGD:1307991 6480464 1, 2-dithiol-3-thione results in decreased expression of SH2D4A mRNA CTD PMID:19162173 acrylamide decreases expression ISO RGD:1307991 6480464 Acrylamide results in decreased expression of SH2D4A mRNA CTD PMID:28959563 benomyl increases expression ISO RGD:1307991 6480464 Benomyl results in increased expression of SH2D4A mRNA CTD PMID:15885261 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of SH2D4A mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1317502 6480464 Benzoapyrene results in increased methylation of SH2D4A 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1317502 6480464 Benzoapyrene affects the methylation of SH2D4A promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1317502 6480464 7 more ... CTD PMID:19150397 Benzo[k]fluoranthene increases expression EXP 6480464 benzokfluoranthene results in increased expression of SH2D4A mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1317502 6480464 Diethylhexyl Phthalate results in increased expression of SH2D4A mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1307991 6480464 bisphenol A affects the expression of SH2D4A mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1307991 6480464 bisphenol A results in decreased expression of SH2D4A mRNA CTD PMID:30816183 bisphenol A increases methylation ISO RGD:1307991 6480464 bisphenol A results in increased methylation of SH2D4A gene CTD PMID:28505145 bromobenzene decreases expression ISO RGD:1307991 6480464 bromobenzene results in decreased expression of SH2D4A mRNA CTD PMID:32479839 calcitriol multiple interactions ISO RGD:1317502 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SH2D4A mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1317502 6480464 Calcitriol results in increased expression of SH2D4A mRNA CTD PMID:21592394 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of SH2D4A mRNA CTD PMID:23125180 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of SH2D4A mRNA CTD PMID:28472532 cobalt dichloride increases expression ISO RGD:1307991 6480464 cobaltous chloride results in increased expression of SH2D4A mRNA CTD PMID:24386269 cyclosporin A decreases expression ISO RGD:1317502 6480464 Cyclosporine results in decreased expression of SH2D4A mRNA CTD PMID:25562108 DDE increases expression ISO RGD:1307991 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of SH2D4A mRNA CTD PMID:15885261 dexamethasone multiple interactions ISO RGD:1317502 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SH2D4A mRNA CTD PMID:28628672 dibutyl phthalate decreases expression ISO RGD:1307991 6480464 Dibutyl Phthalate results in decreased expression of SH2D4A mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1317502 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 flutamide increases expression ISO RGD:1307991 6480464 Flutamide results in increased expression of SH2D4A mRNA CTD PMID:15885261 flutamide decreases expression ISO RGD:1307991 6480464 Flutamide results in decreased expression of SH2D4A mRNA CTD PMID:24136188 indometacin multiple interactions ISO RGD:1317502 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SH2D4A mRNA CTD PMID:28628672 leflunomide decreases expression ISO RGD:1317502 6480464 leflunomide results in decreased expression of SH2D4A mRNA CTD PMID:28988120 leflunomide decreases expression ISO RGD:1307991 6480464 leflunomide results in decreased expression of SH2D4A mRNA CTD PMID:24136188 mercury dibromide multiple interactions ISO RGD:1317502 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SH2D4A mRNA CTD PMID:27188386 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of SH2D4A intron CTD PMID:27776689 nefazodone decreases expression ISO RGD:1307991 6480464 nefazodone results in decreased expression of SH2D4A mRNA CTD PMID:24136188 nimesulide decreases expression ISO RGD:1307991 6480464 nimesulide results in decreased expression of SH2D4A mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO RGD:1307991 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SH2D4A mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:1307991 6480464 oxaliplatin results in decreased expression of SH2D4A mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:1317502 6480464 Acetaminophen results in decreased expression of SH2D4A mRNA CTD PMID:21420995 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SH2D4A mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SH2D4A mRNA CTD PMID:19136022 phenylmercury acetate increases expression ISO RGD:1317502 6480464 Phenylmercuric Acetate results in increased expression of SH2D4A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1317502 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SH2D4A mRNA CTD PMID:27188386 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of SH2D4A mRNA CTD PMID:19136022 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SH2D4A mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:1317502 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of SH2D4A mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1317502 6480464 potassium chromateVI results in decreased expression of SH2D4A mRNA CTD PMID:22079256 rac-lactic acid decreases expression ISO RGD:1317502 6480464 Lactic Acid results in decreased expression of SH2D4A mRNA CTD PMID:30851411 rotenone decreases expression ISO RGD:1307991 6480464 Rotenone results in decreased expression of SH2D4A mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1317502 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sunitinib decreases expression ISO RGD:1317502 6480464 Sunitinib results in decreased expression of SH2D4A mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1317502 6480464 tert-Butylhydroperoxide results in decreased expression of SH2D4A mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1317502 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SH2D4A mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1317502 6480464 Testosterone results in decreased expression of SH2D4A mRNA CTD PMID:21592394 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SH2D4A mRNA CTD PMID:31919559 topotecan multiple interactions ISO RGD:1307991 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SH2D4A mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:1307991 6480464 Topotecan results in decreased expression of SH2D4A mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1317502 6480464 trichostatin A results in increased expression of SH2D4A mRNA CTD PMID:24935251 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of SH2D4A mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SH2D4A mRNA CTD PMID:28973697 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SH2D4A mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:1317502 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SH2D4A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1317502 6480464 Valproic Acid results in increased expression of SH2D4A mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO RGD:1307991 6480464 vinclozolin affects the expression of SH2D4A mRNA CTD PMID:19015723 zoledronic acid increases expression ISO RGD:1317502 6480464 zoledronic acid results in increased expression of SH2D4A mRNA CTD PMID:24714768